COCH
Income statement / Annual
Last year (2025), Envoy Medical Inc's total revenue was $241.00 K,
an increase of 7.11% from the previous year.
In 2025, Envoy Medical Inc's net income was -$23.76 M.
See Envoy Medical Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$241.00 K |
$225.00 K |
$316.00 K |
$237.00 K |
$310.00 K |
$0.00 |
| Cost of Revenue |
$874.00 K
|
$742.00 K
|
$789.00 K
|
$498.00 K
|
$769.00 K
|
$0.00
|
| Gross Profit |
-$633.00 K
|
-$517.00 K
|
-$473.00 K
|
-$261.00 K
|
-$459.00 K
|
$0.00
|
| Gross Profit Ratio |
-2.63
|
-2.3
|
-1.5
|
-1.1
|
-1.48
|
0
|
| Research and Development Expenses |
$12.49 M
|
$10.18 M
|
$8.96 M
|
$4.98 M
|
$3.94 M
|
$0.00
|
| General & Administrative Expenses |
$7.93 M
|
$6.83 M
|
$7.26 M
|
$2.59 M
|
$2.47 M
|
$0.00
|
| Selling & Marketing Expenses |
$1.22 M
|
$1.73 M
|
$1.67 M
|
$885.00 K
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.15 M
|
$8.56 M
|
$8.93 M
|
$3.47 M
|
$2.47 M
|
$701.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$21.64 M
|
$18.74 M
|
$17.89 M
|
$8.45 M
|
$6.41 M
|
$701.00
|
| Cost And Expenses |
$22.51 M
|
$19.48 M
|
$18.68 M
|
$8.94 M
|
$7.18 M
|
$701.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$37.67 K
|
$0.00
|
| Interest Expense |
$1.59 M
|
$816.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$302.00 K
|
$173.00 K
|
$133.00 K
|
$75.00 K
|
$71.00 K
|
$0.00
|
| EBITDA |
-$21.97 M |
-$19.81 M |
-$29.79 M |
-$8.63 M |
-$6.80 M |
-$701.00 |
| EBITDA Ratio |
-91.15
|
-88.03
|
-94.27
|
-36.42
|
-21.94
|
0
|
| Operating Income Ratio |
-92.41
|
-85.58
|
-58.1
|
-36.73
|
-22.16
|
0
|
| Total Other Income/Expenses Net |
-$1.49 M
|
-$1.54 M
|
-$11.56 M
|
-$7.22 M
|
-$1.80 M
|
$0.00
|
| Income Before Tax |
-$23.76 M
|
-$20.80 M
|
-$29.92 M
|
-$15.92 M
|
-$8.68 M
|
-$701.00
|
| Income Before Tax Ratio |
-98.57
|
-92.42
|
-94.69
|
-67.19
|
-27.98
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$23.76 M
|
-$20.80 M
|
-$29.92 M
|
-$15.92 M
|
-$8.68 M
|
-$701.00
|
| Net Income Ratio |
-98.57
|
-92.42
|
-94.69
|
-67.19
|
-27.98
|
0
|
| EPS |
-1.23 |
-1.49 |
-2.54 |
-1.57 |
-1.05 |
0 |
| EPS Diluted |
-1.23 |
-1.49 |
-2.54 |
-1.57 |
-1.05 |
0 |
| Weighted Average Shares Out |
$19.60 M
|
$18.79 M
|
$12.55 M
|
$10.15 M
|
$10.15 M
|
$60.38 M
|
| Weighted Average Shares Out Diluted |
$19.60 M
|
$18.79 M
|
$12.55 M
|
$10.15 M
|
$10.15 M
|
$60.38 M
|
| Link |
|
|
|
|
|
|
